ACTINIUM PHARMACEUTICALS, INC. Proceeds from Issuance of Warrants
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Proceeds from Issuance of Warrants of $47.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2021-03-31
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for the quarter ending 2013-12-31 was $2.00.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for the quarter ending 2013-09-30 was $3.75K.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for fiscal 2020 was $47.00K, a 96.88% decline from fiscal 2019.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for fiscal 2019 was $1.50M, a 0.27% increase from fiscal 2018.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for fiscal 2018 was $1.50M.
- ACTINIUM PHARMACEUTICALS, INC. proceeds from issuance of warrants for fiscal 2013 was $3.47M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month | Proceeds from Issuance of Warrants 157 month | Proceeds from Issuance of Warrants 160 month | Proceeds from Issuance of Warrants 163 month |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $47.00K 10-K · filed 2021-03-31 | ||||||
| 2019-12-31 | $1.50M 10-K · filed 2021-03-31 | ||||||
| 2018-12-31 | $1.50M 10-K · filed 2019-03-15 | ||||||
| 2013-12-31 | $2.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $3.75K derived: sum of 2 quarters · filed 2014-02-28 | $3.47M 10-K · filed 2014-02-28 | $3.47M 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $3.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $3.47M 10-Q · filed 2013-11-14 | $3.47M 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $3.46M 10-Q · filed 2013-08-13 | $3.46M 10-Q · filed 2013-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |